19.12.2013 • NewsAvandiaDede WillamsGlaxoSmithKline (GSK)

Facing Fines, Glaxo SmithKline to Stop Drug Promotion Excesses

UK drugmaker Glaxo SmithKline has said it would cease offering financial incentives to doctors to promote its products through speaking engagements, for example. The company also will stop linking remuneration of its sales representatives to the number of prescriptions generated. Starting from the beginning of 2015 it also will no longer pay healthcare professionals to attend medical conferences.

For years, the pharmaceutical industry has been widely criticized for such practices. The volte-face at Glaxo SmithKline comes on the heels of criminal proceedings launched by the U.S. government earlier this year.

In what is believed to be the largest fraud settlement ever, the company agreed to pay $3 billion in fines and plead guilty to federal charges stemming from kickbacks and other missteps, including marketing the depression drug Paxil to children and teenagers and using fake advisory boards to promote the depression drug Wellburtin as an option for weight loss and as a remedy for sexual dysfunction and substance addiction.

The federal prosecutors said the drugmaker also sponsored dinners and spa programs and at the same time submitting incorrect prices for pharmaceuticals to the government. This allowed it to underpay rebates to government-funded programs such as Medicaid. Glaxo SmithKline also stands accused of failing to report data about the cardiovascular effects of its diabetes drug Avandia to the FDA.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read